Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party-Reference-Cited by-同舟云学术

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Published:2017-09-11 Issue:11 Volume:52 Page:1519-1525
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Scheid C,de Wreede L,van Biezen A,Koenecke C,Göhring G,Volin L,Maertens J,Finke J,Passweg J,Beelen D,Cornelissen J J,Itälä-Remes M,Chevallier P,Russell N,Petersen E,Milpied N,Richard Espiga C,Peniket A,Sierra J,Mufti G,Crawley C,Veelken J H,Ljungman P,Cahn J Y,Alessandrino E P,de Witte T,Robin M,Kröger N

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2017171.pdf

Reference14 articles.

1. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454–2465.

2. Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L, Pascutto C et al. Predictive factors for the outcome of allogeneic transplantation in patients with Mds stratified according to the revised Ipss-R. Blood 2014; 123: 2333–2342.

3. Yahng S-A, Jeon Y-W, Yoon J-H, Shin S-H, Lee S-E, Choi Y-S et al. Dynamic prognostic value of the revised international prognostic scoring system following pretransplant hypomethylating treatment in myelodysplastic syndrome. Bone Marrow Transplant 2016; 52: 522–531.

4. Shaffer BC, Ahn KW, Hu Z-H, Nishihori T, Malone AK, Valcarcel D et al. Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. J Clin Oncol 2016; 34: 1864–1871.

5. Schanz J, Tuchler H, Sole F, Mallo M, Luno E, Cervera J et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (Mds) and oligoblastic acute myeloid leukemia after Mds derived from an International Database Merge. J Clin Oncol 2012; 30: 820–829.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

2. Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS);Blood Reviews;2023-11

3. Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age;Blood Reviews;2023-05

4. Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines;Transplantation and Cellular Therapy;2023-02

5. In the Pipeline: Emerging Therapy for MDS and MDS/MPN;Pathogenesis and Treatment of Leukemia;2023